Standout Papers

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis 2012 2026 2016 2021 1.3k
  1. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis (2012)
    Ralf Gold, Ludwig Kappos et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 67 standout
Sub-graph 1 of 19

Citing Papers

Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
1 intermediate paper

Works of Sarah Sheikh being referenced

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE
2014
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
2012 Standout

Author Peers

Author Last Decade Papers Cites
Sarah Sheikh 1305 449 553 468 48 2.1k
D. H. Silberberg 1119 305 570 519 45 2.4k
Kjetil Bjørnevik 1247 445 593 475 59 2.5k
Joël Oger 1384 437 1108 386 70 2.6k
Mariko Kita 1108 412 409 380 31 1.9k
Clyde Markowitz 1603 237 520 287 58 2.6k
Marianna Cortese 893 334 362 355 43 2.0k
Sharmilee Gnanapavan 890 273 459 358 70 2.5k
Jonatan Salzer 1537 480 624 191 49 2.0k
Jayne Ness 1149 184 846 353 44 2.0k
Björn Tackenberg 824 347 812 608 72 2.7k

All Works

Loading papers...

Rankless by CCL
2026